Altris AI

Altris AI is a specialized medical software that uses artificial intelligence to analyze Optical Coherence Tomography (OCT) scans of the eye. It automatically detects and quantifies over 30 retinal pathologies—including diabetic retinopathy, macular degeneration, and glaucoma—along with more than 40 biomarkers like fluid and geographic atrophy. The tool provides clinicians with detailed, quantitative reports that highlight areas of concern, measure changes over time, and support diagnostic decisions. It works by uploading OCT scans to a web platform, where the AI processes the images and returns annotated results, often in seconds.

What sets Altris AI apart is its focus on the specific needs of eye care. It doesn't just flag anomalies; it provides measurable data that clinicians can use to monitor treatment efficacy, track disease progression, and make consistent decisions across different practice locations. The system is designed to integrate into existing clinical workflows, aiming to reduce the time spent on manual scan review and minimize subjective interpretation errors. It also generates patient-friendly, color-coded visualizations that help explain conditions during consultations.

This tool is most valuable for ophthalmology clinics, optometry practices, and pharmaceutical research teams. Ophthalmologists use it to efficiently monitor complex cases like wet AMD, while optometrists rely on it for accurate referral decisions and standardizing care. For researchers running clinical trials, Altris AI can pre-screen participants, potentially accelerating enrollment and reducing screen failure rates by identifying suitable candidates based on precise scan criteria. It’s a practical assistant for any professional who needs faster, data-driven insights from retinal imaging.